I also heard the news recently. Recently, the research report of ursodeoxycholic acid used to prevent COVID-19 infection has not been verified in clinical trials, and there is still great uncertainty whether it can be used to prevent and treat infection in COVID-19. However, according to this study, researchers from Cambridge University ranked among the best in international academic journals on February 5, 2022. Natural? This article is entitled: fxr inhibition may protect against SARS-cov-2 infection by reducing ace 2? Research paper.

This study, involving organ-like, animal experiments, human donated organs and human patients, shows that ursodeoxycholic acid (UDCA), a liver disease drug whose patent has expired, can prevent COVID-19 infection, and may be able to prevent the infection of future mutants in COVID-19.